Metraipolis › archive › dc_1992d4872970

Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study — Europe PMC PMID:40940918

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940918
DOI
10.3390/cancers17172819
License (as archived)
solo-consultazione
Archived
2026-11-10T06:50:33.109Z
SHA-256 of the archived text
c64808f617dc97e9c0d2345f7d060a405efa21aa7e05507c0349cc9250b1453a
Stable URL of this page
https://metraipolis.com/documento/dc_1992d4872970

How to cite

Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study — Europe PMC PMID:40940918 — Europe PMC (en), https://europepmc.org/article/MED/40940918 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1992d4872970 (Metraipolis archive dc_1992d4872970, sha256 c64808f617dc97e9c0d2345f7d060a405efa21aa7e05507c0349cc9250b1453a)
BibTeX
@misc{dc1992d4872970,
  title = {Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study — Europe PMC PMID:40940918},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940918},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1992d4872970; sha256 c64808f617dc97e9c0d2345f7d060a405efa21aa7e05507c0349cc9250b1453a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940918. Agents can read the archived copy with the MCP tool read_document.